Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Desjardins dropped their FY2025 EPS estimates for shares of Centric Health in a note issued to investors on Sunday, November 10th. Desjardins analyst G. Ho now forecasts that the company will post earnings of $0.10 per share for the year, down from their previous estimate of $0.12.
Several other equities research analysts have also recently weighed in on CRX. Stifel Canada cut Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th. Ventum Cap Mkts raised Centric Health to a “strong-buy” rating in a report on Thursday, August 8th.
Centric Health Price Performance
Read More
- Five stocks we like better than Centric Health
- Stock Market Sectors: What Are They and How Many Are There?
- Rocket Lab is the Right Stock for the Right Time
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is the S&P 500 and How It is Distinct from Other Indexes
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
